Comprehensive Guide to Hidradenitis Suppurativa

Despite being a relatively straightforward clinical diagnosis, recognition of hidradenitis suppurativa (HS) is highly variable, and clinical management is challenging and complex. Written by the world’s leading experts in HS, A Comprehensive Guide to Hidradenitis Suppurativa brings together up-to-date scientific evidence on the diagnosis, patho-mechanisms, comorbidities, and multi-faceted medical and surgical interventions for this debilitating condition—in one convenient reference. 

Key Features

• Covers every aspect of this complex skin disorder: etiology, pathophysiology, epidemiology, medical, alternative therapies, a range of surgical options, laser treatments, and comorbidities. 

• Discusses specific patient populations such as children, women of childbearing potential, and pregnant and breastfeeding women. Because HS has higher prevalence in people of skin of color, this patient population is well-documented in the text.  

• Offers insights into multi-disciplinary care, patient support and education, patients at risk for rapid disease progression, and clinical and translational research. 

• Features procedural videos covering laser therapies, de-roofing procedures, excision techniques, cryoinsufflation techniques, and special wound care material selection and techniques. 

• Includes promising future drugs and therapies that are under investigation.

• Identifies evidence gaps that provide a springboard to the future innovations in HS care to come. 

• Edited and authored by global experts who have helped co-author U. S., Canadian, and European guidelines on HS.  

• Enhanced eBook version included with purchase. Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices. 

Chapter # Chapter Title
Front Matter and Preface
Section 1: Introduction to HS
1 Historic Perspectives
2 Epidemiology
3 Clinical Manifestations and Phenotypes
4 Differential Diagnosis
5 Histopathology
6 Imaging Modalities
7 Clinical Evaluation
8 Comorbidities and Systemic Associations
9 Disease Complications
Section 2: Pathogenesis
10 Follicular Occlusion and Inflammation
11 Microbiome
12 Genetics and Epigenetics
Section 3: Clinician's Corner
13 Management and Outcome Measure Guidelines
14 Topical Therapeutics
15 Systemic Antibiotics
16 Non-Antibiotic Systemic Therapeutics for HS
17 Targeted Therapeutics: Biologics, Small Molecules
18 Pain and Itch Control
19 Wound Care
20 Quality of Life
21 Office-Based Non-Excision Procedures
22 Office-Based Surgical Excision
23 OR-Based Surgical Procedures
24 Laser and Light-Based Treatments
25 Other Procedural Treatments
26 Lifestyle Modifications
27 Complementary and Alternative Medicine (CAM)
Section 4: Special Populations
28 Pediatrics
29 Skin of Color
30 Women of Childbearing Age
Section 5: Combined Approach
31 HS Action Plan
32 HS Multi-Disciplinary Approach
33 HS Support Groups
Section 6: On the Horizon
34 Pipeline Therapeutics
35 The Future
Index

Author Information

By Vivian Y. Shi, MD, Associate Professor, Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U. S. A.; Jennifer L. Hsiao, MD, Assistant Clinical Professor of Dermatology, Director, Hidradenitis Suppurativa Specialty Clinic, University of California, Los Angeles, California; Michelle A. Lowes, MD, PhD, Associate Professor of Clinical Investigation, The Laboratory for Investigative Dermatology, Rockefeller University, New York, New York and Iltefat H. Hamzavi, MD, Henry Ford Hospital, Clinical Associate Professor, Department of Dermatology, Wayne State University SOM; President, HS Foundation, Detroit, Michigan

RECENZII